News
STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
More in Health
- STAT+: Why a Huntington’s patient isn’t fazed by the waning effect of UniQure’s gene therapy STAT
- 20 fascinating facts about hair: why baldness is super-masculine – and a pubic bush could be a ‘cheating detector’ The Guardian — Society
- Trump administration reverses stance on integration of people with disabilities NPR — Health
- Inside India's forest villages, where a dangerous mix of crises led to 32 child deaths BBC News — Health
- Medical Records Firm Uses AI Tool to Expose Flaws that Threaten Patient Privacy The New York Times — Health